BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Begg A, van der Kogel A. Clinical radiobiology in 2008. Radiother Oncol 2008;86:295-9. [PMID: 18313778 DOI: 10.1016/j.radonc.2008.02.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
Number Citing Articles
1 Rodemann HP. Molecular radiation biology: Perspectives for radiation oncology. Radiotherapy and Oncology 2009;92:293-8. [DOI: 10.1016/j.radonc.2009.08.023] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 2.8] [Reference Citation Analysis]
2 Zips D, Le K, Yaromina A, Dörfler A, Eicheler W, Zhou X, Geyer P, Hilberg F, Baumann M. Triple angiokinase inhibition, tumour hypoxia and radiation response of FaDu human squamous cell carcinomas. Radiotherapy and Oncology 2009;92:405-10. [DOI: 10.1016/j.radonc.2009.04.006] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
3 Bufacchi A, Nardiello B, Capparella R, Begnozzi L. Clinical implications in the use of the PBC algorithm versus the AAA by comparison of different NTCP models/parameters. Radiat Oncol. 2013;8:164. [PMID: 23826854 DOI: 10.1186/1748-717x-8-164] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
4 Bufacchi A, Arcangeli G, Canne SD, Malatesta T, Capparella R, Fragomeni R, Marmiroli L, Begnozzi L. Comparison between the ideal reference dose level and the actual reference dose level from clinical 3D radiotherapy treatment plans. Radiotherapy and Oncology 2009;92:68-75. [DOI: 10.1016/j.radonc.2009.02.018] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]